Flaten Deanna, Berrigan Liam, Spirkina Anna, Gin Alfred
, BScPharm, ACPR, is with the Winnipeg Regional Health Authority Pharmacy Program, Winnipeg, Manitoba.
, BScPharm, ACPR, is with Horizon Health Network, Dr Everett Chalmers Regional Hospital, Fredericton, New Brunswick.
Can J Hosp Pharm. 2023 Jan 9;76(1):14-22. doi: 10.4212/cjhp.3264. eCollection 2023 Winter.
Prosthetic joint infections (PJIs) are a major complication of total joint replacement surgeries. Treatment includes surgical intervention with prolonged courses of IV antibiotics in outpatient parenteral antimicrobial therapy (OPAT) programs. The risk of PJI treatment failure is high and may be associated with various clinical factors.
To determine the rate of PJI treatment failure and to identify potential risk factors for failure in patients admitted to an OPAT program.
A retrospective chart review was conducted for adult patients with PJI admitted to an OPAT program between July 1, 2013, and July 1, 2019. Treatment courses were deemed to have failed according to predetermined criteria. χ tests and multiple linear regression were used to examine associations of comorbidities, pathogens, and antimicrobial regimens with treatment failure.
In total, 100 patients associated with 137 PJI treatment courses in the OPAT program were included. Of these, 28 patients accounted for 65 of the treatment courses. Methicillin-susceptible was the most frequently isolated pathogen (31/137 or 22.6% of treatment courses). Patient comorbidities included body mass index of at least 30 kg/m (58% of patients) and diabetes (41% of patients). The overall rate of treatment failure was 56.2% (77/137 treatment courses). Selected risk factors associated with treatment failure or success were diabetes (50.9% versus 29.8%; odds ratio [OR] 4.03, 95% confidence interval [CI] 1.38-12.88, = 0.013) and depression (32.1% versus 14.9%; OR 5.02, 95% CI 1.30-22.89, = 0.025).
The overall rate of PJI treatment failure in the study population was high. Patients with diabetes and depression experienced higher incidences of failure. Future investigations of comprehensive PJI management should be considered to ensure successful treatment and to minimize excessive use of health care resources.
人工关节感染(PJI)是全关节置换手术的主要并发症。治疗方法包括在门诊胃肠外抗菌治疗(OPAT)项目中进行手术干预并延长静脉使用抗生素的疗程。PJI治疗失败的风险很高,且可能与多种临床因素相关。
确定OPAT项目收治患者中PJI治疗失败的发生率,并识别治疗失败的潜在风险因素。
对2013年7月1日至2019年7月1日期间收治于OPAT项目的成年PJI患者进行回顾性病历审查。根据预定标准判定治疗疗程失败。采用χ检验和多元线性回归分析合并症、病原体及抗菌治疗方案与治疗失败之间的关联。
OPAT项目中共有100例患者涉及137个PJI治疗疗程。其中,28例患者占65个治疗疗程。甲氧西林敏感菌是最常分离出的病原体(31/137,占治疗疗程的22.6%)。患者的合并症包括体重指数至少为30kg/m²(58%的患者)和糖尿病(41%的患者)。总体治疗失败率为56.2%(77/137个治疗疗程)。与治疗失败或成功相关的选定风险因素为糖尿病(50.9%对29.8%;优势比[OR]4.03,95%置信区间[CI]1.38 - 12.88,P = 0.013)和抑郁症(32.1%对14.9%;OR 5.02,95% CI 1.30 - 22.89,P = 0.025)。
研究人群中PJI治疗失败的总体发生率较高。糖尿病和抑郁症患者的失败发生率更高。应考虑对PJI综合管理进行进一步研究,以确保治疗成功并尽量减少医疗资源的过度使用。